Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates 3D-woven dECM yarn scaffolds promote muscle regeneration in animal models, suggesting a tunable biomaterial platform for functional repair.
Volumetric muscle loss (VML) represents a significant unmet clinical need in current medical practice. Decellularized extracellular matrix (dECM) offers a promising clinical approach. However, its inherent architecture impedes adaptive topological guidance for rapid cellular infiltration, spatial organization, and coordinated immune response, limiting functional restoration. Here, we report a dECM yarn scaffold (YS) fabricated by 3D weaving of rotary-cut yarns, achieving precise structural control, full interconnectivity and high porosity. In murine VML models, YS significantly improved vascularization, innervation, muscle mass, and strength restoration. Single-nucleus RNA-sequencing identified decreased SPP1+ neutrophil infiltration alongside increased CD206+/IGF-1+ macrophages, whose enhanced IGF-1 secretion stimulated PAX7+ muscle cell growth via amplified IGF-1R signaling. The robust regenerative efficacy and translational potential of YS was further confirmed in a canine VML model. Our study shows that restructured dECM scaffolds address structural constraints to enable effective in situ muscle regeneration, while simultaneously establishing a novel scaffold platform for regenerative medicine. Volumetric muscle loss remains a significant unmet clinical need. Herein, the authors report a yarn scaffold based on decellularized extracellular matrix fabricated via 3D weaving of rotary-cut yarns, which achieves precise structural control, full interconnectivity, and high porosity.
No takes yet. Share an insight, caveat, or question.
Song et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: